Source document or public record

FDA 510(k) K253839 — Elecsys Anti-SARS-CoV-2

FDA 510(k) index record K253839. Device: Elecsys Anti-SARS-CoV-2. Applicant as listed: Roche Diagnostics. Decision date: 2025-12-17.

OtherU.S. Food and Drug Administration (FDA)2025-12-17

Source

"device_name": "Elecsys Anti-SARS-CoV-2"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K253839.

Device name: Elecsys Anti-SARS-CoV-2. Applicant as listed: Roche Diagnostics.

Decision date: 2025-12-17. Decision wording: Substantially Equivalent.

Product code: QVP. Regulation: 21 CFR 866.3983. Medical specialty: Microbiology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.